References

1. Wolf E, Dramer R, Blum W, Foll J, Brem G. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth. Endocrinology 1994;135:1877-1886.

2. Nucci AM, Reyes J, Yaworski JA, Mazariegos G, Beserock N, Barksdale EM, Jr. Serum growth factors and growth indices pre- and post-pediatric intestinal transplantation. Journal of Pediatric Surgery. 2003;38:1043-7.

3. Iannoli P, Miller JH, Ryan CK, Gu LH, Ziegler TR, Sax HC. Human growth hormone induces system B transport in short bowel syndrome. Journal of Surgical Research. 1997;69:150-8.

4. Yang H, Wildhaber BE, Teitelbaum DH. Keratinocyte growth factor improves epithelial function after massive small bowel resection. JPEN J Parenter Enteral Nutr 2003;27:198-206; discussion 206-7.

5. Yang H, Antony PA, Wildhaber BE, Teitelbaum DH. Intestinal intraepithelial lymphocyte gamma delta-T cell-derived keratinocyte growth factor modulates epithelial growth in the mouse. J Immunol 2004;172:4151-8.

6. Stern LE, Falcone RA, Jr., Kemp CJ, Braun MC, Erwin CR, Warner BW. Salivary epidermal growth factor and intestinal adaptation in male and female mice. American Journal of Physiology - Gastrointestinal & Liver Physiology 2000;278:G871-7.

7. Jeppesen PB, Hartmann B, Thulesen J, Hansen BS, Holst JJ, Poulsen SS, Mortensen PB. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut. 2000;47:370-6.

8. Barksdale EM, Jr., Koehler AN, Yaworski JA, Gardner M, Reyes J. Insulinlike growth factor 1 and insulinlike growth factor 3: indices of intestinal failure in children. Journal of Pediatric Surgery. 1999;34:655-61; discussion 661-2.

9. Sigalet D, Martin G, Meddings J, Hartman B, Holst J. GLP-2 Levels in Infants With Intestinal Dysfunction. Pediatr Res 2004;56:1-6.

10. Jeppesen PB, Mortensen PB. Enhancing bowel adaptation in short bowel syndrome. Current Gastroenterology Reports. 2002;4:338-47.

11. Iannoli P, Miller JH, Sax HC. Epidermal growth factor and human growth hormone induce two sodium-dependent arginine transport systems after massive enterectomy. JPEN J Parenter Enteral Nutr 1998;22:326-30.

12. Iannoli P, Miller J, Ryan C, Gu L, Ziegler TR, Sax HC. Epidermal growth factor and human growth hormone accelerate adpatation after massive enterectomy in an additive, nutrient-dependent, and site-specific fashion. Surgery 1997;122:721-729.

13. Vanderhoof JA, Kollman KA, Griffin CA. Growth hormone and glutamine do not stimulate intestinal adaptation following massive small bowel resection in the rat. J Pediatr Gastro Nutr 1997;25:327-331.

14. Ziegler T, Mantell M, Chow J, Rombeau J, Smith R. Gut adaptation and the insulin-like growth factor system: regulation by glutamine and IGF-I administration. Am J Physiol;271:G866-875.

15. Zhou X, Li YX, Li N, Li JS. Effect of bowel rehabilitative therapy on structural adaptation of remnant small intestine: animal experiment. World Journal of Gastroenterology. 2001;7:66-73.

16. Helmrath MA, Shin CE, Erwin CR, Warner BW. The EGF/EGF-receptor axis modulates enterocyte apoptosis during intestinal adaptation. J Surg Res 1998;77:17-22.

17. Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Mortensen PB. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.[see comment]. Gastroenterology. 2001;120:806-15.

18. Coran AG, Spivak D, Teitelbaum DH. An analysis of the morbidity and mortality of short-bowel syndrome in the pediatric age group. European Journal of Pediatric Surgery 1999;9:228-30.

19. Teitelbaum D, Drongowski R, Spivak D. Rapid development of hyperbilirubinemia in infants with the short bowel syndrome as a correlate to mortality: Possible indication for early small bowel transplantation. Trans Proc 1996;28:2677-2678.

20. Jonas C, Gu L, Nkabyo Y, Mannery Y, Avissar N, HC S, Jones D, TR Z. Glutamine and KGF each regulate extracellular thiol/disulfide redox and enhance proliferation in Caco-2 cells. Am J Physiol 2003;285:R1421-R1429.

21. Wildhaber BE, Yang H, Teitelbaum DH. Keratinocyte Growth Factor decreases total parenteral nutrition-induced apoptosis in mouse intestinal epithelium via Bcl-2. J Pediatr Surg 2003;38:92-6.

22. Spencer K, Graus-Porta D, Leng J, Hynes N, Klemke R. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. J Cell Biol 2000;148:385-397.

23. Farrell C, Rex K, Chen J, Bready J, DiPalma C, Kaufman S, Rattan A, Scully S, Lacey D. The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Proliferation 2002;1:78-85.

24. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995;222:243-54; discussion 254-5.

25. Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.[see comment]. Gastroenterology. 2003;124:293-302.

26. Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Mortensen PB. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001;120:806-15.

27. Tsai C, Hill M, Drucker K. Biological determinants of intestinotrophic properties of GLP-2 in vivo. American Journal of Physiology 1997;272:G662-G668.

28. Drucker D, Erlich P, SL A, Brubaker P. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 1996;93:7911-7916.

29. Boismenu R, Chen Y, Havran WL. The role of intraepithelial gammadelta T cells: a gut-feeling. Microbes Infect 1999;1:235-40.

30. Johnson W, DiPalma C, Ziegler T, Scully S, Farrell C. Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome. Vet Surg 2000;29:17-27.

31. Xia G, Martin A, Michalsky M, Besner G. Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury. J Ped Surg 2002;37:1081-7.

32. Drucker D. Epithelial cell growth and differentiation I. Intestinal growth factors. Am J Physiol 1997;273:G3-G6.

33. Liu Q, Du XX, Schindel DT, Yang ZX, Rescorla FJ, Williams DA, Grosfeld JL. Trophic effects of interleukin-11 in rats with experimental short bowel syndrome. Journal of Pediatric Surgery. 1996;31:1047-50; discussion 1050-1.

34. Fiore NF, Ledniczky G, Liu Q, Orazi A, Du X, Williams DA, Grosfeld JL. Comparison of interleukin-11 and epidermal growth factor on residual small intestine after massive small bowel resection. Journal of Pediatric Surgery. 1998;33:24-9.

35. de Miguel E, Gomez de Segura IA, Bonet H, Rodriguez Montes JA, Mata A. Trophic effects of neurotensin in massive bowel resection in the rat. Digestive Diseases & Sciences. 1994;39:59-64.

36. Schlemminger R, Lottermoser S, Sostmann H, Kohler H, Nustede R, Schafmayer A. [Metabolic parameters and neurotensin liberation after resection of the small intestine, syngeneic and allogeneic segment transplantation the rat]. Langenbecks Archiv fur Chirurgie. 1993;378:265-72.

37. Andrews NJ, Irving MH. Human gut hormone profiles in patients with short bowel syndrome. Digestive Diseases & Sciences 1992;37:729-32.

38. Mannon P. Peptide YY as a growth factor for intestinal epithelium. Peptides 2002;23:383-388.

39. Wu X, Spies M, Chappell V, Herndon D, Thompson J, SE W. Effect of bombesin on gut mucosal impairment after severe burn. Shock 2002;18:518-522.

40. Alexander AN, Carey HV. Oral IGF-I enhances nutrient and electrolyte absorption in neonatal piglet intestine. Am J Physiol 1999;277:G619-25.

41. O'Brien DP, Nelson LA, Williams JL, Kemp CJ, Erwin CR, Warner BW. Selective inhibition of the epidermal growth factor receptor impairs intestinal adaptation after small bowel resection. Journal of Surgical Research 2002;105:25-30.

42. Erwin CR, Helmrath MA, Shin CE, Falcone RAJ, Stern LE, Warner BW. Intestinal overexpression of EGF in transgenic mice enhances adaptation after small bowel resection. American Journal of Physiology 1999;277:G533-40.

43. Byrne TA, Cox S, Karimbakas M, Veglia LM, Bennett HM, Lautz DB, Robinson MK, Wilmore DW. Bowel rehabilitation: an alternative to long-term parenteral nutrition and intestinal transplantation for some patients with short bowel syndrome. Transplantation Proceedings. 2002;34:887-90.

44. Byrne TA, Morrissey TB, Nattakom TV, Ziegler TR, Wilmore DW. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. Journal of Parenteral and Enteral Nutrition 1995;19:296-302.

45. Schwartz MZ, Kato Y, Yu D, Lukish JR. Growth-factor enhancement of compromised gut function following massive small-bowel resection. Pediatric Surgery International 2000;16:174-5.

46. Nishimura S, Takahashi M, Ota S, Hirano M, Hiraishi H. Hepatocyte growth factor accelerates restitution of intestinal epithelial cells. Journal of Gastroenterology 1998;33:172-8.

47. Pearson P, O'Connor D, Schwartz M. Novel effect of leptin on small intestine adaptation. J Surg Res 2001;97:192-195.

48. Todisco A, Ramamoorthy S, Witham T, Pausawasdi N, Srinivasan S, Dickinson C, Askari F, Krametter D. Molecular mechanisms for the antiapoptotic action of gastrin. American Journal of Physiology - Gastrointestinal & Liver Physiology 2001;280:G298-307.

49. Dockray G, Varro A, Dimaline R, Wang T. The gastrins: their production and biological activities. Annu Rev Physiol 2001;63:119-139.